学术探索
学术期刊
新闻热点
数据分析
智能评审

SOCS proteins, cytokine signalling and immune regulation

被引：1270
作者：
Yoshimura, Akihiko
Naka, Tetsuji
Kubo, Masato
机构：
[1] Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Higashi Ku, Fukuoka 8128582, Japan
[2] Natl Inst Biomed Innovat, Lab Immune Signal, Ibaraki, Osaka 5670085, Japan
[3] RIKEN Yokohama Inst, Lab Signal Network, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan
来源：
NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 06期
关键词：
D O I：
10.1038/nri2093
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Suppressor of cytokine signalling (SOCS) proteins are inhibitors of cytokine signalling pathways. Studies have shown that SOCS proteins are key physiological regulators of both innate and adaptive immunity. These molecules positively and negatively regulate macrophage and dendritic-cell activation and are essential for T-cell development and differentiation. Evidence is also emerging of the involvement of SOCS proteins in diseases of the immune system. In this Review we bring together data from recent studies on SOCS proteins and their role in immunity, and propose a cohesive model of how cytokine signalling regulates immune-cell function.
引用
收藏
页码：454 / 465
页数：12
相关论文
共 112 条
  • [51] Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo
    Li, Yonghai
    Chu, Niansheng
    Rostami, Abdolmohamad
    Zhang, Guang-Xian
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (03) : 1679 - 1688
  • [52] V-Abl signaling disrupts SOCS-1 function in transformed pre-B cells
    Limnander, A
    Danial, NN
    Rothman, PB
    [J]. MOLECULAR CELL, 2004, 15 (03) : 329 - 341
  • [53] Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent
    Machado, FS
    Johndrow, JE
    Esper, L
    Dias, A
    Bafica, A
    Serhan, CN
    Aliberti, J
    [J]. NATURE MEDICINE, 2006, 12 (03) : 330 - 334
  • [54] Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation
    Mansell, A
    Smith, R
    Doyle, SL
    Gray, P
    Fenner, JE
    Crack, PJ
    Nicholson, SE
    Hilton, DJ
    O'Neill, LAJ
    Hertzog, PJ
    [J]. NATURE IMMUNOLOGY, 2006, 7 (02) : 148 - 155
  • [55] Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line
    Melzner, I
    Bucur, AJ
    Brüderlein, S
    Dorsch, K
    Hasel, C
    Barth, TFE
    Leithäuser, F
    Möller, P
    [J]. BLOOD, 2005, 105 (06) : 2535 - 2542
  • [56] A network model for the control of the differentiation process in Th cells
    Mendoza, Luis
    [J]. BIOSYSTEMS, 2006, 84 (02) : 101 - 114
  • [57] Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form
    Mujtaba, MG
    Flowers, LO
    Patel, CB
    Patel, RA
    Haider, MI
    Johnson, HM
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 175 (08) : 5077 - 5086
  • [58] The JAK-STAT signaling pathway: Input and output intergration
    Murray, Peter J.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (05) : 2623 - 2629
  • [59] NAGAKIOHARA K, 2006, GUT, V55, P212
  • [60] Negative regulation of cytokine and TLR signalings by SOCS and others
    Naka, T
    Fujimoto, M
    Tsutsui, H
    Yoshimura, A
    [J]. ADVANCES IN IMMUNOLOGY, VOL 87, 2005, 87 : 61 - +
12345678910